Peculiarites of interaction between 3-(2-aminophenyl)-6-R-1,2,4-triazin-5(2H)-ones and cyclic anhydrides of non-symmetric dicarboxylic acids
DOI:
https://doi.org/10.24959/ophcj.15.817Keywords:
anhydrides of non-symmetric dicarboxylic acids, cyclisation, X-ray experimentAbstract
The peculiarities of the reaction between 3-(2-aminophenyl)-6-R-1,2,4-triazin-5(2H)-ones and cyclic anhydrides of non-symmetric (2-methylsuccinic, 2-phenylsuccinic and camphoric) acids have been described in the present article. The influence of electronic and steric effects of substituents in the anhydride molecule on cyclisation processes has been discussed. The results have shown that the interaction of 3-(2-aminophenyl)-6-R-1,2,4-triazin- 5(2H)-ones mentioned above with 2-methylsuccinic and 2-phenylsuccinic acid anhydrides proceeded non-selectively and yielded the mixtures of 2-R1-3-(2-oxo-3-R-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)propanoic acids and 1-(2-(5-oxo-6-R-2,5-dihydro-1,2,4-triazin-3-yl)phenyl)-3-R1-pyrrolidine-2,5-diones. It has been found that low regioselectivity of the acylation process may be explained by insignificant electronic effects of substituents (of the methyl and phenyl fragment) in position 2 of the anhydride molecule on the electrophilic reaction centre. It has been also determined that the reaction between 3-(2-aminophenyl)-6-R-1,2,4-triazin-5(2H)-ones and camphoric anhydride proceeds regioselectively and yielded 1,2,2-trimethyl-3-(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin- 6-yl)cyclopentan-1-carboxylic acids. Regioselectivity of the interaction mentioned above may be explained by the steric effect of the methyl group. Identity of compounds has been proven by LC-MS, the structure has been determined via a set of characteristic signals in 1H NMR, 13C NMR spectra and position of cross peaks in the correlation HSQC-experiment. Mass spectra of the compounds synthesized have been also studied, the principal directions of the molecule fragmentation have been described. The structure of 1,2,2-trimethyl-3-(3-methyl- 2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)cyclopentane-1-carboxylic acid has been proven by X-ray analysis.
Downloads
References
- Sergeieva T. Yu., Voskoboynik O. Yu., Okovytyy S. I., Kovalenko S. I., Shishkina S. V., Shishkin O. V., Leszczynski J. J. Phys. Chem. A., 2014, 118, pp.1895-1905. doi: 10.1021/jp4052616.
- Kovalenko S. I., Nosulenko I. S., Voskoboynik A. Yu., Berest G. G., Antipenko L. M., Antipenko A. N., Katsev A. M. Med. Chem. Res., 2013, 22(6), pp.2610-2632. doi: 10.1007/s00044-012-0257-x.
- Kovalenko S. I., Nosulenko I. S., Voskoboynik A. Yu., Berest G. G., Antipenko L. M., Antipenko A. N., Katsev A. M. Sci. Pharm., 2012, 80, pp.837-865.10.3797/scipharm.1208-07.
- Berest G. G., Voskoboynik O. Yu., Kovalenko S. I., Nosulenko I. S., Antipenko L. M., Antipenko O. M., Shvets V. M., Katsev A. M. Sci. Pharm., 2012, 80 (1), pp.37-65. doi:10.3797/scipharm.1111-15.
- Berest G. G., Voskoboynik A. Yu., Kovalenko S. I., Antipenko A. M., Nosulenko I. S., Katsev A. M., Shandrovskaya A. S. Eur. J. Med. Chem., 2011, 46 (12), pp.6066-6074. doi: 10.1016/j.ejmech.2011.10.022.
- Voskoboynik A. Yu., Scorina D. Yu., Sergeieva T. Yu., Kovalenko S. I., Okovytyy S. I., Omelchenko I. V., Shishkin O. V. J. Het. Chem. (in press) doi: 10.1002/jhet.2120.
- UA Utility Model Patent №U201214626 Salts of (3-R-8-R1-9-R2-10-R3-11-R4-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl) alkylcarboxylic acids improving physical endurance of body Stepaniuk H. I., Pochelova O. V., Chornoivan N. H., Voskoboinik O. Y., Skoryna D. Y., Kovalenko S. I. Published 20.12.2012.
- UA Utility Model Patent №U201306088 Use of sodium salt of 4-(2-oxo-3-methyl-2H-[1,2,4]triazino[2,3-c]-quinazolin-6-yl) butanoic acid as cerebroprotective agents Semenenko N. O., Stepaniuk H. I., Semenenko A. I., Kovalenko S. I., Voskoboinik O. Yu., Skoryna D. Yu. Published 17.05.2013.
- UA Utility Model Patent №U 2001064232 Antidiabetic agent “Diakamf”, which reveals the hypoglycemic, antidiabetogenic and antioxidant action Merzlikin S. I., Chernykh V. P., Hladkykh O. I., Chueshov V. I., Pashnev P. D. Published 15.04.2002.
- Karpenko O. V., Kovalenko S. I., Chekotylo O. O., Shishkina S. V. Heterocycles, 2007, 71 (3), pp.619-626. doi: 10.3987/COM-06-10971.
- Zefirov Yu. V. Crystallography, 1997, 42 (5), pp.936-958.
- Burgi H.-B., Dunitz J. D. Structure correlation. Vol. 2. VCH. Weinheim. 1994, pp.741-784.
- Sheldrick G. M. Acta Crystallogr., Sect. A, 2008, A64, pp.112-122.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).